One Hundred Thirteenth Congress of the United States of America
2d Session
Begun and held at the City of Washington on Friday, the third day of January, two thousand and fourteen
S. 2338
AN ACT
To reauthorize the United States Anti-Doping Agency, and for other purposes.
Short title
This Act may be cited as the
United States Anti-Doping Agency Reauthorization Act
.
Prohibit performance-enhancing methods
Section 701 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006 (21 U.S.C. 2001) is amended—
in subsection (a), by striking paragraph (4); and
in subsection (b)—
in paragraph (1), by inserting and be recognized worldwide as the independent
national anti-doping organization for the United States
after Committee
;
in paragraph (2), by striking , or performance-enhancing genetic modifications accomplished
through gene-doping
and inserting or prohibited performance-enhancing methods adopted by the Agency
;
in paragraph (3), by striking , or performance-enhancing genetic modifications accomplished
through gene-doping
and inserting or prohibited performance-enhancing methods adopted by the Agency
;
in paragraph (4), by striking and the prevention of use of performance-enhancing drugs, or performance-enhancing
genetic modifications accomplished through gene-doping by
United States amateur athletes; and
and inserting , and the prevention of use by United States amateur athletes of performance-enhancing drugs or
prohibited performance-enhancing methods adopted by the Agency.
; and
by striking paragraph (5).
Authorization of appropriations
Section 703 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006 (21 U.S.C. 2003) is amended to read as follows:
Authorization of appropriations
There are authorized to be appropriated to the United States Anti-Doping Agency—
for fiscal year 2014, $11,300,000;
for fiscal year 2015, $11,700,000;
for fiscal year 2016, $12,300,000;
for fiscal year 2017, $12,900,000;
for fiscal year 2018, $13,500,000;
for fiscal year 2019, $14,100,000; and
for fiscal year 2020, $14,800,000.
.
Speaker of the House of Representatives
Vice President of the United States and President of the Senate